Search Results - morpholinos

1 Results

Sort By:

Radioprotectants and Tumor Radiosensitizers Targeting Thrombospondin-1 and CD47

Abstract: The National Cancer Institute''s Laboratory of Pathology is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize CD47-targeting agents as radioprotectants and tumor sensitizers. Radiation therapy not only damages cancer cells, but it also damages healthy...

Published: 4/8/2024 | Inventor(s): David Roberts, Justin Maxhimer, Jeff Isenberg

Keywords(s): CANCER, CD47, Morpholinos, Radioprotective Agents, Radiotherapeutics, Thrombospondin-1 (TSP1), Tumor Sensitizers

Category(s): Collaboration Sought > Licensing